Abstract: The present invention relates to a method and system for using a hemofilter to treat IMRD, hepatic failure, exogenous intoxication and other conditions associated with toxins in a patient's blood. One treatment includes the use of a very large pore hemofilter to remove target complex molecules and/or target molecules from a patient's blood and to infuse a replacement fluid into the patient's blood to maintain a prescribed albumin concentration in the patient's blood.
Type:
Grant
Filed:
March 23, 2006
Date of Patent:
April 21, 2009
Assignee:
Imunocept, L.L.C.
Inventors:
David Radunsky, James R. Matson, Patrice A. Lee